Daniel Dobson, MBA '95, questions a panelist at the NU Today Cancer Research Panel.
Published: |
|
---|---|
Online Access: | http://hdl.handle.net/2047/d20166223 |
Summary: |
---|
Published: |
|
---|---|
Online Access: | http://hdl.handle.net/2047/d20166223 |
Summary: |
---|